Dyne Therapeutics, Inc. (DYN) Description, Stock price, News & Info.

#ThinkSabio Latest News

Announces New Long-Term Data from Phase 1/2 DELIVER Trial of DYNE-251 in DMD Demonstrating Unprecedented and Sustained Functional Improvement Through 18 Months

Leave a Reply

Your email address will not be published. Required fields are marked *